A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo

Journal of Cell Science

Volumn 123, Issue 6, 2010, Pages 960-971

  Shavlakadze, Thea ^a   Chai, Jinfen ^a   Maley, Kirsten ^a   Cozens, Greg ^a   Grounds, Griffin ^a   Winn, Nadine ^b   Rosenthal, Nadia ^b   Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

Growth; IGF 1; Skeletal muscle

Indexed keywords

MYOGENIN; PROTEIN KINASE B; SERINE; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; DYSTROPHY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HORMONE ACTION; IN VIVO STUDY; MALE; MOUSE; MOUSE STRAIN; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MUSCLE LEVEL; MUSCLE MASS; MUSCLE NECROSIS; MUSCLE REGENERATION; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STRAIN DIFFERENCE; TASTE; TRANSGENIC MOUSE; WILD TYPE;

AGING; ANIMALS; BODY WEIGHT; GENE EXPRESSION REGULATION; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOGENIN; ORGAN SIZE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 77951169963     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.061119     Document Type: Article

References (59)

1. Adamo, M., Lowe, W. L., Jr, LeRoith, D. and Roberts, C. T., Jr (1989). Insulin-like growth factor I messenger ribonucleic acids with alternative 5′-untranslated regions are differentially expressed during development of the rat. Endocrinology 124, 2737-2744.
2. Adamo, M. L., Ben-Hur, H., Roberts, C. T., Jr and LeRoith, D. (1991). Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol. Endocrinol. 5, 1677-1686.
3. Adams, G. R. (2000). Insulin-like growth factor in muscle growth and its potential abuse by athletes. Br. J. Sports Med. 34, 412-413.
4. Bark, T. H., McNurlan, M. A., Lang, C. H. and Garlick, P. J. (1998). Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am. J. Physiol. 275, E118-E123.
5. Barton, E. R. (2006). Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J. Appl. Physiol. 100, 1778-1784.
6. Beilharz, M. W., Lareu, R. R., Garrett, K. L., Grounds, M. D. and Fletcher, S. (1992). Quantitation of muscle precursor cell activity in skeletal muscle by northern analysis of MyoD and myogenin expression-application to dystrophic (mdx) mouse muscle. Mo. Cell. Neurosci. 3, 326-331.
7. Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Strover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J. et al. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 3, 1014-1019.
8. Burattini, S., Ferri, P., Battistelli, M., Curci, R., Luchetti, F. and Falcieri, E. (2004). C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur. J. Histochem. 48, 223-233.
9. Butler, A. A., Ambler, G. R., Breier, B. H., LeRoith, D., Roberts, C. T., Jr and Gluckman, P. D. (1994). Growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment of the GH-deficient dwarf rat: differential effects on IGF-I transcription start site expression in hepatic and extrahepatic tissues and lack of effect on type I IGF receptor mRNA expression. Mol. Cell Endocrinol. 101, 321-330.
10. Chakravarthy, M. V., Fiorotto, M. L., Schwartz, R. J. and Booth, F. W. (2001). Long-term insulin-like growth factor-I expression in skeletal muscles attenuates the enhanced in vitro proliferation ability of the resident satellite cells in transgenic mice. Mech. Ageing Dev. 122, 1303-1320.
11. Chiang, G. G. and Abraham, R. T. (2005). Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem 280, 25485-25490.
12. Corradetti, M. N. and Guan, K. L. (2006). Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25, 6347-6360.
13. Davis, T. A. and Fiorotto, M. L. (2009). Regulation of muscle growth in neonates. Curr. Opin. Clin. Nutr. Metab. Care 12, 78-85.
14. Davis, T. A., Burrin, D. G., Fiorotto, M. L. and Nguyen, H. V. (1996). Protein synthesis in skeletal muscle and jejunum is more responsive to feeding in 7-than in 26-day-old pigs. Am. J. Physiol. 270, E802-E809.
15. Dennis, P. B., Pullen, N., Kozma, S. C. and Thomas, G. (1996). The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell. Biol. 16, 6242-6251.
16. Donoghue, M. J., Alvarez, J. D., Merlie, J. P. and Sanes, J. R. (1991). Fiber type- and position-dependent expression of a myosin light chain-CAT transgene detected with a novel histochemical stain for CAT. J. Cell Biol. 115, 423-434.
17. Fernandez, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I. and Le Roith, D. (2001). Functional inactivation of the IGF-1 and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 15, 1926-1934.
18. Fiorotto, M. L., Schwartz, R. J. and Delaughter, M. C. (2003). Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth. FASEB J. 17, 59-60.
19. Glass, D. J. (2003). Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5, 87-90.
20. Grounds, M. D., Radley, H. G., Lynch, G. S., Nagaraju, K. and De Luca, A. (2008). Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis. 31, 1-19.
21. Hamalainen, N. and Pette, D. (1993). The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J. Histochem. Cytochem. 41, 733-743.
22. Hameed, M., Orrell, R. W., Cobbold, M., Goldspink, G. and Harridge, S. D. (2003). Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. 547, 247-254.
23. Hemmings, B. A. (1997). PtdIns(3,4,5)P3 gets its message across. Science 277, 534.
24. Hornberger, T. A., Stuppard, R., Conley, K. E., Fedele, M. J., Fiorotto, M. L., Chin, E. R. and Esser, K. A. (2004). Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem. J. 380, 795-804.
25. Inoki, K., Li, Y., Zhu, T., Wu, J. and Guan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648-657.
26. Kuemmerle, J. F. (2003). IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G411-G422.
27. Le Roith, D., Scavo, L. and Butler, A. (2001). What is the role of circulating IGF-I? Trends Endocrinol. Metab. 12, 48-52.
28. Lee, C. H., Inoki, K. and Guan, K. L. (2007). mTOR pathway as a target in tissue hypertrophy. Annu. Rev. Pharmacol. Toxicol. 47, 443-467.
29. Lee, S., Barton, E. R., Sweeney, H. L. and Farrar, R. P. (2004). Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J. Appl. Physiol. 96, 1097-1104.
30. Li, M., Li, C. and Parkhouse, W. S. (2002). Differential effects of des IGF-1 on Erks, AKT-1 and P70 S6K activation in mouse skeletal and cardiac muscle. Mol. Cell Biochem. 236, 115-122.
31. Li, M., Li, C. and Parkhouse, W. S. (2003). Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle. Mech. Ageing Dev. 124, 771-778.
32. Liao, L., Dearth, R. K., Zhou, S., Britton, O. L., Lee, A. V. and Xu, J. (2006). Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147, 3877-3888.
33. Lowe, W. L., Jr, Roberts, C. T., Jr, Lasky, S. R. and LeRoith, D. (1987). Differential expression of alternative 5′ untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 84, 8946-8950.
34. Lynch, G. S. (2001). Therapies for improving muscle function in neuromuscular disorders. Exerc. Sport Sci. Rev. 29, 141-148.
35. Musaro, A. and Rosenthal, N. (1999). Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell. Biol. 19, 3115-3124.
36. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., Sweeney, H. L. and Rosenthal, N. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200.
37. Naranjo, W. M., Yakar, S., Sanchez-Gomez, M., Perez, A. U., Setser, J. and LeRoith, D. (2002). Protein calorie restriction affects nonhepatic IGF-I production and the lymphoid system: studies using the liver-specific IGF-I gene-deleted mouse model. Endocrinology 143, 2233-2241.
38. Paul, A. C. and Rosenthal, N. (2002). Different modes of hypertrophy in skeletal muscle fibers. J. Cell Biol. 156, 751-760.
39. Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E. and Thomas, G. (1995). The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14, 5279-5287.
40. Price, D. J., Mukhopadhyay, N. K. and Avruch, J. (1991). Insulin-activated protein kinases phosphorylate a pseudosubstrate synthetic peptide inhibitor of the p70 S6 kinase. J. Biol. Chem. 266, 16281-16284.
41. Reynolds, T. H. t., Bodine, S. C. and Lawrence, J. C., Jr (2002). Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem. 277, 17657-17662.
42. Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D. and Glass, D. J. (2001). Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013.
43. Rosenthal, N., Kornhauser, J. M., Donoghue, M., Rosen, K. M. and Merlie, J. P. (1989). Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7780-7784.
44. Ruvinsky, I. and Meyuhas, O. (2006). Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348.
45. Sans, M. D., Lee, S. H., D'Alecy, L. G. and Williams, J. A. (2004). Feeding activates protein synthesis in mouse pancreas at the translational level without increase in mRNA. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G667-G675.
46. Sekulic, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M. and Abraham, R. T. (2000). A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60, 3504-3513.
47. Shavlakadze, T. and Grounds, M. (2006). Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. BioEssays 28, 994-1009.
48. Shavlakadze, T., White, J., Hoh, J. F., Rosenthal, N. and Grounds, M. D. (2004). Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Mol. Ther. 10, 829-843.
49. Shavlakadze, T., White, J. D., Davies, M., Hoh, J. F. and Grounds, M. D. (2005a). Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy. Neuromuscul. Disord. 15, 139-146.
50. Shavlakadze, T., Winn, N., Rosenthal, N. and Grounds, M. D. (2005b). Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 15, 4-18.
51. Shavlakadze, T., Boswell, J. M., Burt, D. W., Asante, E. A., Tomas, F. M., Davies, M. J., White, J. D., Grounds, M. D. and Goddard, C. (2006). Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration, denervation and muscular dystrophy. Growth Horm IGF Res. 16, 157-173.
52. Shemer, J., Adamo, M. L., Roberts, C. T., Jr and LeRoith, D. (1992). Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. Endocrinology 131, 2793-2799.
53. Song, Y. H., Godard, M., Li, Y., Richmond, S. R., Rosenthal, N. and Delafontaine, P. (2005). Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J. Investig. Med. 53, 135-142.
54. Suryawan, A., Orellana, R. A., Nguyen, H. V., Jeyapalan, A. S., Fleming, J. R. and Davis, T. A. (2007). Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated. Am. J. Physiol. Endocrinol. Metab. 293, E1597-E1605.
55. Tolosa, L., Morla, M., Iglesias, A., Busquets, X., Llado, J. and Olmos, G. (2005). IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. Cell Signal 17, 1333-1342.
56. Valentinis, B., Navarro, M., Zanocco-Marani, T., Edmonds, P., McCormick, J., Morrione, A., Sacchi, A., Romano, G., Reiss, K. and Baserga, R. (2000). Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J. Biol. Chem. 275, 25451-25459.
57. Weng, Q. P., Kozlowski, M., Belham, C., Zhang, A., Comb, M. J. and Avruch, J. (1998). Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273, 16621-16629.
58. Yakar, S., Pennisi, P., Wu, Y., Zhao, H. and LeRoith, D. (2005). Clinical relevance of systemic and local IGF-I. Endocr. Dev. 9, 11-16.
59. Yarasheski, K., Zachwieja, J., Campbell, J. and Bier, D. (1995). Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am. J. Physiol. Am. J. Physiol. 268, E268-E276.